Prothena

$23.37
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$1.46 (+6.66%) Today
$0.00 (0.00%) As of 12:00 AM UTC after-hours

Why Robinhood?

You can buy or sell Prothena and other stocks, options, and ETFs commission-free!

About PRTA

Prothena Corporation plc Ordinary Shares, also called Prothena, is a clinical-stage neuroscience company. It focuses on the discovery and development of novel therapies to change the course of devastating diseases.

CEO
Gene G. Kinney
Employees
66
Headquarters
Dun Laoghaire, Dublin
Founded
1969
Market Cap
1.10B
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
397.09K
High Today
$24.20
Low Today
$21.73
Open Price
$22.28
Volume
314.85K
52 Week High
$28.66
52 Week Low
$9.25

PRTA Earnings

-$0.77
-$0.51
-$0.26
$0.00
Q3 FY19
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Estimated
— per share
Actual
Expected May 6, Pre-Market

You May Also Like

GAINL
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure